These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 34049825)

  • 1. Epigenome editing of the CFTR-locus for treatment of cystic fibrosis.
    Kabadi AM; Machlin L; Dalal N; Lee RE; McDowell I; Shah NN; Drowley L; Randell SH; Reddy TE
    J Cyst Fibros; 2022 Jan; 21(1):164-171. PubMed ID: 34049825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Cas9 and Cas12a CRISPR editing methods to correct the W1282X-CFTR mutation.
    Santos L; Mention K; Cavusoglu-Doran K; Sanz DJ; Bacalhau M; Lopes-Pacheco M; Harrison PT; Farinha CM
    J Cyst Fibros; 2022 Jan; 21(1):181-187. PubMed ID: 34103250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stabilization of Foxp3 expression by CRISPR-dCas9-based epigenome editing in mouse primary T cells.
    Okada M; Kanamori M; Someya K; Nakatsukasa H; Yoshimura A
    Epigenetics Chromatin; 2017; 10():24. PubMed ID: 28503202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRISPR/Cas9-based epigenome editing: An overview of dCas9-based tools with special emphasis on off-target activity.
    Tadić V; Josipović G; Zoldoš V; Vojta A
    Methods; 2019 Jul; 164-165():109-119. PubMed ID: 31071448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal and Spatial Epigenome Editing Allows Precise Gene Regulation in Mammalian Cells.
    Kuscu C; Mammadov R; Czikora A; Unlu H; Tufan T; Fischer NL; Arslan S; Bekiranov S; Kanemaki M; Adli M
    J Mol Biol; 2019 Jan; 431(1):111-121. PubMed ID: 30098338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highly specific epigenome editing by CRISPR-Cas9 repressors for silencing of distal regulatory elements.
    Thakore PI; D'Ippolito AM; Song L; Safi A; Shivakumar NK; Kabadi AM; Reddy TE; Crawford GE; Gersbach CA
    Nat Methods; 2015 Dec; 12(12):1143-9. PubMed ID: 26501517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted Activation of Cystic Fibrosis Transmembrane Conductance Regulator.
    Villamizar O; Waters SA; Scott T; Saayman S; Grepo N; Urak R; Davis A; Jaffe A; Morris KV
    Mol Ther; 2019 Oct; 27(10):1737-1748. PubMed ID: 31383454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protocol for Allele-Specific Epigenome Editing Using CRISPR/dCas9.
    Rajaram N; Bashtrykov P; Jeltsch A
    Methods Mol Biol; 2024; 2842():179-192. PubMed ID: 39012596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR-based epigenome editing: mechanisms and applications.
    Fadul SM; Arshad A; Mehmood R
    Epigenomics; 2023 Nov; 15(21):1137-1155. PubMed ID: 37990877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional repression of PTEN in neural cells using CRISPR/dCas9 epigenetic editing.
    Moses C; Hodgetts SI; Nugent F; Ben-Ary G; Park KK; Blancafort P; Harvey AR
    Sci Rep; 2020 Jul; 10(1):11393. PubMed ID: 32647121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protocol for Delivery of CRISPR/dCas9 Systems for Epigenetic Editing into Solid Tumors Using Lipid Nanoparticles Encapsulating RNA.
    Woodward EA; Wang E; Wallis C; Sharma R; Tie AWJ; Murthy N; Blancafort P
    Methods Mol Biol; 2024; 2842():267-287. PubMed ID: 39012601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transgenic mice for in vivo epigenome editing with CRISPR-based systems.
    Gemberling MP; Siklenka K; Rodriguez E; Tonn-Eisinger KR; Barrera A; Liu F; Kantor A; Li L; Cigliola V; Hazlett MF; Williams CA; Bartelt LC; Madigan VJ; Bodle JC; Daniels H; Rouse DC; Hilton IB; Asokan A; Ciofani M; Poss KD; Reddy TE; West AE; Gersbach CA
    Nat Methods; 2021 Aug; 18(8):965-974. PubMed ID: 34341582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo epigenome editing and transcriptional modulation using CRISPR technology.
    Lau CH; Suh Y
    Transgenic Res; 2018 Dec; 27(6):489-509. PubMed ID: 30284145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ezh2-dCas9 and KRAB-dCas9 enable engineering of epigenetic memory in a context-dependent manner.
    O'Geen H; Bates SL; Carter SS; Nisson KA; Halmai J; Fink KD; Rhie SK; Farnham PJ; Segal DJ
    Epigenetics Chromatin; 2019 May; 12(1):26. PubMed ID: 31053162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Harnessing CRISPR-Cas9 for Epigenetic Engineering.
    Guerra-Resendez RS; Hilton IB
    Methods Mol Biol; 2022; 2518():237-251. PubMed ID: 35666449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P.F508del editing in cells from cystic fibrosis patients.
    Smirnikhina SA; Kondrateva EV; Adilgereeva EP; Anuchina AA; Zaynitdinova MI; Slesarenko YS; Ershova AS; Ustinov KD; Yasinovsky MI; Amelina EL; Voronina ES; Yakushina VD; Tabakov VY; Lavrov AV
    PLoS One; 2020; 15(11):e0242094. PubMed ID: 33175893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR-Mediated Transcriptional Repression in Toxoplasma gondii.
    Markus BM; Boydston EA; Lourido S
    mSphere; 2021 Oct; 6(5):e0047421. PubMed ID: 34643425
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Zhou ZP; Yang LL; Cao H; Chen ZR; Zhang Y; Wen XY; Hu J
    Hum Gene Ther; 2019 Sep; 30(9):1101-1116. PubMed ID: 31099266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prime editing functionally corrects cystic fibrosis-causing CFTR mutations in human organoids and airway epithelial cells.
    Bulcaen M; Kortleven P; Liu RB; Maule G; Dreano E; Kelly M; Ensinck MM; Thierie S; Smits M; Ciciani M; Hatton A; Chevalier B; Ramalho AS; Casadevall I Solvas X; Debyser Z; Vermeulen F; Gijsbers R; Sermet-Gaudelus I; Cereseto A; Carlon MS
    Cell Rep Med; 2024 May; 5(5):101544. PubMed ID: 38697102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of Cell Lines Stably Expressing a dCas9-Fusion or sgRNA to Address Dynamics of Long-Term Effects of Epigenetic Editing.
    Sarno F; Koncz M; Eilers RE; Verschure PJ; Rots MG
    Methods Mol Biol; 2024; 2842():289-307. PubMed ID: 39012602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.